A federal deadline is approaching for companies working with a specific form of engineered nanomaterial, following regulatory action taken by the Environmental Protection Agency earlier this month. The EPA’s new rules governing
Sandoz has struck a major deal with China’s Shanghai Henlius Biotechnology, securing commercialisation rights to three biosimilars currently in early development. The Swiss pharmaceutical company will pay up to $100.5 million upfront
More
Mariam El-Sobky, a Lincoln’s Inn barrister, has been disbarred following a disciplinary tribunal that uncovered multiple serious professional breaches spanning several years. El-Sobky was found to have secretly recorded family court proceedings
More
The FTSE 100 has pulled back from its record high in recent weeks, prompting fresh debate about whether the index can reclaim that ground before summer ends. The index hit an all-time
More
The FTSE 100 extended its losing streak to six straight sessions, weighed down by weakness across consumer-facing stocks on the London Stock Exchange. The index has faced sustained selling pressure over several
More
AstraZeneca has reported positive phase 3 results from two separate non-small cell lung cancer trials, though the wins have done little to offset a significant setback elsewhere in its pipeline. The British
More
The One Big Beautiful Bill Act, signed into law on July 4, 2025, has made the most significant changes to Section 1202 of the Internal Revenue Code in fifteen years. The legislation,
More
London’s blue-chip index advanced on Monday, clawing back some losses after falling 1.4% during the previous week amid shifting expectations for U.S. monetary policy. The FTSE 100 gained 0.26% as of 03:25
More
Britain’s businesses are being strangled by a relentless accumulation of policy-driven costs that have built up over the past decade, leaving little room for growth. Before a single pound of profit is
More
EyePoint Pharmaceuticals (EYPT) saw its stock collapse by more than 70% on Monday after its drug-device combination Duravyu stumbled in its first of two phase 3 trial readouts this year. The company
More
Gloria Hunniford’s salary changed over the course of her career and contributed significantly to her net worth. Gloria Hunniford remains one of Britain’s most enduring broadcasting figures, with a career now spanning
More